Alkem Laboratories Ltd. Company Cyber Security Posture

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea รขโ‚ฌโ€œ The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of Indiaรขโ‚ฌโ„ขs largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of รขโ‚ฌหœExtended Lifecare Beyond Boundariesรขโ‚ฌโ„ข.

ALL Company Details

Linkedin ID:

alkem-laboratories-ltd

Employees number:

10,001+ employees

Number of followers:

0

NAICS:

325

Industry Type:

Pharmaceutical Manufacturing

Homepage:

alkemlabs.com

IP Addresses:

Scan still pending

Company ID:

ALK_3196569

Scan Status:

In-progress

AI scoreALL Risk Score (AI oriented)

Between 800 and 900

This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.

Ailogo

Alkem Laboratories Ltd. Company Scoring based on AI Models

Model NameDateDescriptionCurrent Score DifferenceScore
AVERAGE-Industry03-12-2025

This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers.

N/A

Between 800 and 900

Alkem Laboratories Ltd. Company Cyber Security News & History

Past Incidents
0
Attack Types
0
EntityTypeSeverityImpactSeenUrl IDDetailsView

Alkem Laboratories Ltd. Company Subsidiaries

SubsidiaryImage

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea รขโ‚ฌโ€œ The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of Indiaรขโ‚ฌโ„ขs largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of รขโ‚ฌหœExtended Lifecare Beyond Boundariesรขโ‚ฌโ„ข.

Loading...

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=alkem-laboratories-ltd' -H 'apikey: YOUR_API_KEY_HERE'
newsone

ALL Cyber Security News

2025-05-15T07:00:00.000Z
Alkem Labs US arm hit by cyber fraud; financial loss under probe

The incident involved the compromise of business email accounts belonging to certain employees, resulting in the fraudulent transfer of funds.

2025-05-16T07:00:00.000Z
Cybersecurity incident at Alkem Labs US arm, investigation underway

Mumbai: Alkem Labs has announced that its subsidiary Enzene Biosciences Limited has detected a cyber security incident on its US subsidiary.

2025-05-15T07:00:00.000Z
Enzene Biosciences Cyberattack Leads To Fund Theft

A Enzene Biosciences cyberattack led to a fraudulent fund transfer via compromised emails.

2025-05-16T07:00:00.000Z
Alkem reports cyber security incident at Enzeneโ€™s US subsidiary

Alkem Laboratories reports cyber security incident resulting in fraudulent fund transfer at Enzene Biosciences, investigation underway.

2025-05-17T07:00:00.000Z
Pharma Giant Hit by Cyber Fraud; Financial Loss Under Probe

The attack involved compromised business email accounts belonging to multiple employees, which were subsequently used to facilitate fraudulentย ...

2025-02-06T08:00:00.000Z
Alkem Labs duped of โ‚น22 cr by frauds pretending to be officials of its US arm

Alkem Laboratories, a multinational pharmaceautical company headquartered in Mumbai, has been duped of โ‚น22.31 crore by unidentified cyber frauds.

2025-02-08T08:00:00.000Z
Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud

Alkem Laboratories, a Mumbai-based pharmaceutical company, recently became a victim of a sophisticated cyber scam, resulting in a loss of Rs 22.31 crore.

2024-01-12T08:00:00.000Z
Alkem Labs reports 'fraudulent transfer' of Rs 52 crore from cyber-security breach

Alkem Laboratories has said that "a cyber security incident" has led to a fraudulent transfer of Rs 52 crores.

2023-11-07T06:52:20.000Z
Alkem Laboratories - Check Point Software

Alkem Laboratories is one of the leading pharmaceutical companies in India. It operates 23 manufacturing facilities in India and the United States, supportsย ...

similarCompanies

ALL Similar Companies

Zydus Group

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl

Alembic Pharmaceuticals Limited

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol

Hetero Drugs Ltd

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm

Cephalon

Follow the Teva Pharmaceuticals company page www.linkedin.com/company/teva-pharmaceuticals for information, career opportunities and the latest company updates. Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market

Intas Pharmaceuticals

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc

Bristol Myers Squibb

At Bristol Myers Squibb, we work every day to transform patientsโ€™ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers youโ€™ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating wit

faq

Frequently Asked Questions (FAQ) on Cybersecurity Incidents

ALL CyberSecurity History Information

Total Incidents: According to Rankiteo, ALL has faced 0 incidents in the past.

Incident Types: As of the current reporting period, ALL has not encountered any cybersecurity incidents.

Total Financial Loss: The total financial loss from these incidents is estimated to be {total_financial_loss}.

Cybersecurity Posture: The company's overall cybersecurity posture is described as A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea รขโ‚ฌโ€œ The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of Indiaรขโ‚ฌโ„ขs largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of รขโ‚ฌหœExtended Lifecare Beyond Boundariesรขโ‚ฌโ„ข..

Detection and Response: The company detects and responds to cybersecurity incidents through {description_of_detection_and_response_process}.

Incident Details

Incident 1: Ransomware Attack

Title: {Incident_Title}

Description: {Brief_description_of_the_incident}

Date Detected: {Detection_Date}

Date Publicly Disclosed: {Disclosure_Date}

Date Resolved: {Resolution_Date}

Type: {Type_of_Attack}

Attack Vector: {Attack_Vector}

Vulnerability Exploited: {Vulnerability}

Threat Actor: {Threat_Actor}

Motivation: {Motivation}

Incident 2: Data Breach

Title: {Incident_Title}

Description: {Brief_description_of_the_incident}

Date Detected: {Detection_Date}

Date Publicly Disclosed: {Disclosure_Date}

Date Resolved: {Resolution_Date}

Type: {Type_of_Attack}

Attack Vector: {Attack_Vector}

Vulnerability Exploited: {Vulnerability}

Threat Actor: {Threat_Actor}

Motivation: {Motivation}

Common Attack Types: As of now, the company has not encountered any reported incidents involving common cyberattacks.

Identification of Attack Vectors: The company identifies the attack vectors used in incidents through {description_of_identification_process}.

Impact of the Incidents

Incident 1: Ransomware Attack

Financial Loss: {Financial_Loss}

Data Compromised: {Data_Compromised}

Systems Affected: {Systems_Affected}

Downtime: {Downtime}

Operational Impact: {Operational_Impact}

Conversion Rate Impact: {Conversion_Rate_Impact}

Revenue Loss: {Revenue_Loss}

Customer Complaints: {Customer_Complaints}

Brand Reputation Impact: {Brand_Reputation_Impact}

Legal Liabilities: {Legal_Liabilities}

Identity Theft Risk: {Identity_Theft_Risk}

Payment Information Risk: {Payment_Information_Risk}

Incident 2: Data Breach

Financial Loss: {Financial_Loss}

Data Compromised: {Data_Compromised}

Systems Affected: {Systems_Affected}

Downtime: {Downtime}

Operational Impact: {Operational_Impact}

Conversion Rate Impact: {Conversion_Rate_Impact}

Revenue Loss: {Revenue_Loss}

Customer Complaints: {Customer_Complaints}

Brand Reputation Impact: {Brand_Reputation_Impact}

Legal Liabilities: {Legal_Liabilities}

Identity Theft Risk: {Identity_Theft_Risk}

Payment Information Risk: {Payment_Information_Risk}

Average Financial Loss: The average financial loss per incident is {average_financial_loss}.

Commonly Compromised Data Types: The types of data most commonly compromised in incidents are {list_of_commonly_compromised_data_types}.

Incident 1: Ransomware Attack

Entity Name: {Entity_Name}

Entity Type: {Entity_Type}

Industry: {Industry}

Location: {Location}

Size: {Size}

Customers Affected: {Customers_Affected}

Incident 2: Data Breach

Entity Name: {Entity_Name}

Entity Type: {Entity_Type}

Industry: {Industry}

Location: {Location}

Size: {Size}

Customers Affected: {Customers_Affected}

Response to the Incidents

Incident 1: Ransomware Attack

Incident Response Plan Activated: {Yes/No}

Third Party Assistance: {Yes/No}

Law Enforcement Notified: {Yes/No}

Containment Measures: {Containment_Measures}

Remediation Measures: {Remediation_Measures}

Recovery Measures: {Recovery_Measures}

Communication Strategy: {Communication_Strategy}

Adaptive Behavioral WAF: {Adaptive_Behavioral_WAF}

On-Demand Scrubbing Services: {On_Demand_Scrubbing_Services}

Network Segmentation: {Network_Segmentation}

Enhanced Monitoring: {Enhanced_Monitoring}

Incident 2: Data Breach

Incident Response Plan Activated: {Yes/No}

Third Party Assistance: {Yes/No}

Law Enforcement Notified: {Yes/No}

Containment Measures: {Containment_Measures}

Remediation Measures: {Remediation_Measures}

Recovery Measures: {Recovery_Measures}

Communication Strategy: {Communication_Strategy}

Adaptive Behavioral WAF: {Adaptive_Behavioral_WAF}

On-Demand Scrubbing Services: {On_Demand_Scrubbing_Services}

Network Segmentation: {Network_Segmentation}

Enhanced Monitoring: {Enhanced_Monitoring}

Incident Response Plan: The company's incident response plan is described as {description_of_incident_response_plan}.

Third-Party Assistance: The company involves third-party assistance in incident response through {description_of_third_party_involvement}.

Data Breach Information

Incident 2: Data Breach

Type of Data Compromised: {Type_of_Data}

Number of Records Exposed: {Number_of_Records}

Sensitivity of Data: {Sensitivity_of_Data}

Data Exfiltration: {Yes/No}

Data Encryption: {Yes/No}

File Types Exposed: {File_Types}

Personally Identifiable Information: {Yes/No}

Prevention of Data Exfiltration: The company takes the following measures to prevent data exfiltration: {description_of_prevention_measures}.

Handling of PII Incidents: The company handles incidents involving personally identifiable information (PII) through {description_of_handling_process}.

Ransomware Information

Incident 1: Ransomware Attack

Ransom Demanded: {Ransom_Amount}

Ransom Paid: {Ransom_Paid}

Ransomware Strain: {Ransomware_Strain}

Data Encryption: {Yes/No}

Data Exfiltration: {Yes/No}

Ransom Payment Policy: The company's policy on paying ransoms in ransomware incidents is described as {description_of_ransom_payment_policy}.

Data Recovery from Ransomware: The company recovers data encrypted by ransomware through {description_of_data_recovery_process}.

Regulatory Compliance

Ransomware Logo

Incident 1: Ransomware Attack

Regulations Violated: {Regulations_Violated}

Fines Imposed: {Fines_Imposed}

Legal Actions: {Legal_Actions}

Regulatory Notifications: {Regulatory_Notifications}

Data Breach Logo

Incident 2: Data Breach

Regulations Violated: {Regulations_Violated}

Fines Imposed: {Fines_Imposed}

Legal Actions: {Legal_Actions}

Regulatory Notifications: {Regulatory_Notifications}

Regulatory Frameworks: The company complies with the following regulatory frameworks regarding cybersecurity: {list_of_regulatory_frameworks}.

Ensuring Regulatory Compliance: The company ensures compliance with regulatory requirements through {description_of_compliance_measures}.

Lessons Learned and Recommendations

Incident 1: Ransomware Attack

Lessons Learned: {Lessons_Learned}

Incident 2: Data Breach

Lessons Learned: {Lessons_Learned}

Incident 1: Ransomware Attack

Recommendations: {Recommendations}

Incident 2: Data Breach

Recommendations: {Recommendations}

Key Lessons Learned: The key lessons learned from past incidents are {list_of_key_lessons_learned}.

Implemented Recommendations: The company has implemented the following recommendations to improve cybersecurity: {list_of_implemented_recommendations}.

References

Incident 1: Ransomware Attack

Source: {Source}

URL: {URL}

Date Accessed: {Date_Accessed}

Incident 2: Data Breach

Source: {Source}

URL: {URL}

Date Accessed: {Date_Accessed}

Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at {list_of_additional_resources}.

Investigation Status

Incident 1: Ransomware Attack

Investigation Status: {Investigation_Status}

Incident 2: Data Breach

Investigation Status: {Investigation_Status}

Communication of Investigation Status: The company communicates the status of incident investigations to stakeholders through {description_of_communication_process}.

Stakeholder and Customer Advisories

Incident 1: Ransomware Attack

Stakeholder Advisories: {Stakeholder_Advisories}

Customer Advisories: {Customer_Advisories}


Incident 2: Data Breach

Stakeholder Advisories: {Stakeholder_Advisories}

Customer Advisories: {Customer_Advisories}

Advisories Provided: The company provides the following advisories to stakeholders and customers following an incident: {description_of_advisories_provided}.

Initial Access Broker

Incident 1: Ransomware Attack

Entry Point: {Entry_Point}

Reconnaissance Period: {Reconnaissance_Period}

Backdoors Established: {Backdoors_Established}

High Value Targets: {High_Value_Targets}

Data Sold on Dark Web: {Yes/No}

Incident 2: Data Breach

Entry Point: {Entry_Point}

Reconnaissance Period: {Reconnaissance_Period}

Backdoors Established: {Backdoors_Established}

High Value Targets: {High_Value_Targets}

Data Sold on Dark Web: {Yes/No}

Monitoring and Mitigation of Initial Access Brokers: The company monitors and mitigates the activities of initial access brokers through {description_of_monitoring_and_mitigation_measures}.

Post-Incident Analysis

Incident 1: Ransomware Attack

Root Causes: {Root_Causes}

Corrective Actions: {Corrective_Actions}

Incident 2: Data Breach

Root Causes: {Root_Causes}

Corrective Actions: {Corrective_Actions}

Post-Incident Analysis Process: The company's process for conducting post-incident analysis is described as {description_of_post_incident_analysis_process}.

Corrective Actions Taken: The company has taken the following corrective actions based on post-incident analysis: {list_of_corrective_actions_taken}.

Additional Questions

General Information

Ransom Payment History: The company has {paid/not_paid} ransoms in the past.

Last Ransom Demanded: The amount of the last ransom demanded was {last_ransom_amount}.

Last Attacking Group: The attacking group in the last incident was {last_attacking_group}.

Incident Details

Most Recent Incident Detected: The most recent incident detected was on {most_recent_incident_detected_date}.

Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on {most_recent_incident_publicly_disclosed_date}.

Most Recent Incident Resolved: The most recent incident resolved was on {most_recent_incident_resolved_date}.

Impact of the Incidents

Highest Financial Loss: The highest financial loss from an incident was {highest_financial_loss}.

Most Significant Data Compromised: The most significant data compromised in an incident was {most_significant_data_compromised}.

Most Significant System Affected: The most significant system affected in an incident was {most_significant_system_affected}.

Response to the Incidents

Third-Party Assistance in Most Recent Incident: The third-party assistance involved in the most recent incident was {third_party_assistance_in_most_recent_incident}.

Containment Measures in Most Recent Incident: The containment measures taken in the most recent incident were {containment_measures_in_most_recent_incident}.

Data Breach Information

Most Sensitive Data Compromised: The most sensitive data compromised in a breach was {most_sensitive_data_compromised}.

Number of Records Exposed: The number of records exposed in the most significant breach was {number_of_records_exposed}.

Ransomware Information

Highest Ransom Demanded: The highest ransom demanded in a ransomware incident was {highest_ransom_demanded}.

Highest Ransom Paid: The highest ransom paid in a ransomware incident was {highest_ransom_paid}.

Regulatory Compliance

Highest Fine Imposed: The highest fine imposed for a regulatory violation was {highest_fine_imposed}.

Most Significant Legal Action: The most significant legal action taken for a regulatory violation was {most_significant_legal_action}.

Lessons Learned and Recommendations

Most Significant Lesson Learned: The most significant lesson learned from past incidents was {most_significant_lesson_learned}.

Most Significant Recommendation Implemented: The most significant recommendation implemented to improve cybersecurity was {most_significant_recommendation_implemented}.

References

Most Recent Source: The most recent source of information about an incident is {most_recent_source}.

Most Recent URL for Additional Resources: The most recent URL for additional resources on cybersecurity best practices is {most_recent_url}.

Investigation Status

Current Status of Most Recent Investigation: The current status of the most recent investigation is {current_status_of_most_recent_investigation}.

Stakeholder and Customer Advisories

Most Recent Stakeholder Advisory: The most recent stakeholder advisory issued was {most_recent_stakeholder_advisory}.

Most Recent Customer Advisory: The most recent customer advisory issued was {most_recent_customer_advisory}.

Initial Access Broker

Most Recent Entry Point: The most recent entry point used by an initial access broker was {most_recent_entry_point}.

Most Recent Reconnaissance Period: The most recent reconnaissance period for an incident was {most_recent_reconnaissance_period}.

Post-Incident Analysis

Most Significant Root Cause: The most significant root cause identified in post-incident analysis was {most_significant_root_cause}.

Most Significant Corrective Action: The most significant corrective action taken based on post-incident analysis was {most_significant_corrective_action}.

What Do We Measure?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge